CClinicalTrials.gg
CompletedNCT07748910Updated Aug 6, 2026

Enhancing Resilience and Quality of Life in Bipolar Disorder Through Cognitive Behavioral Therapy

An interventional study of CBT-Based Psychological Resilience Enhancement Program for Individuals with BD in Bipolar Affective Disorder; Remission in, sponsored by Cumhuriyet University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Cumhuriyet University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 years 2 months after the study started (first participant enrolled May 2021, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Bipolar disorder (BD) is a chronic and recurrent mood disorder characterized by alternating episodes of mania, depression, or mixed states, interspersed with periods of remission. These episodes can severely impair interpersonal relationships, occupational functioning, and overall quality of life. In 2019, approximately 40 million people worldwide were diagnosed with BD.

BD is a lifelong chronic condition despite pharmacotherapy and lifestyle changes. Traditional psychiatric care has primarily focused on symptom reduction and relapse prevention, often overlooking broader psychosocial aspects such as interpersonal functioning and life satisfaction. Recently, recovery has come to include living a meaningful life despite illness-related challenges.

Psychological resilience has gained prominence within this recovery framework. It refers to the capacity to adapt positively to adversity, shaped by both internal traits and external supports. Core elements include effective coping, adaptability, and recovery from stress, which support functional outcomes in mental illness.

Given the strong link between stress and relapse in BD, resilience is thought to play a critical role in illness trajectory. Research consistently shows that individuals with BD have lower resilience than healthy controls, and resilience is associated with fewer depressive symptoms and better quality of life.

Importantly, resilience is modifiable and can be enhanced through psychosocial interventions. Studies highlight the benefits of resilience-building programs in reducing depressive vulnerability and improving life satisfaction and emotion regulation. Among these, CBT effectively promotes cognitive and functional recovery in BD by targeting maladaptive thought patterns and building adaptive coping skills.

Despite growing evidence, few CBT-based interventions target resilience in individuals with BD. However, resilience is linked to key psychosocial competencies such as problem-solving, self-efficacy, assertiveness, and self-management. Based on this, the current study implemented a CBT-based Psychological Resilience Enhancement Program designed to strengthen adaptive coping and functional adjustment in individuals with BD.

Considering the substantial personal and societal burden of BD, enhancing psychological resilience is a critical therapeutic goal. This study aimed to evaluate the effects of a CBT-based intervention on psychological resilience and quality of life in individuals with BD.

02

Conditions studied

  • Bipolar Affective Disorder; Remission in

Browse trials for

Keywords

  • bipolar disorder
  • CBT
  • resilience
  • quality of life
  • psychiatric nurse
03

In context

Bipolar Disorder

1,601 studies on the registry are indexed under Bipolar Disorder; 254 are open to participants now.

This study's enrollment of 22 is below the median of 64 across 1,223 interventional studies indexed under Bipolar Disorder.

Browse Bipolar Disorder studies →

Lead sponsor

Cumhuriyet University is the lead sponsor of 128 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged between 18 and 60 years
  • Minimum of primary school education
  • Ability to communicate verbally
  • Score ≤ 5 on the YMRS
  • Score ≤ 17 on the BDI
  • Residence within the city center
  • Voluntary participation with signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of intellectual disability
  • Speech or hearing impairment
  • Presence of comorbid psychiatric disorders
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • No intervention
    Standard Treatment

    The control group simply continued treatment. In Türkiye, standard treatment consists of medication use, prescriptions every three to six months, and outpatient check-ups for laboratory tests such as drug levels. In the study, however, patients in the control group were interviewed, their questions about their illness and treatment were answered, and their general condition was assessed. Treatment adherence levels were determined based on their remission status. It consists of a total of 12 individuals with bipolar disorders

  • Experimental
    Resilience Improvement Program

    The intervention is based on the assumption that individuals with high psychological resilience cope better with psychosocial stressors, return to normal life more quickly after stressful events, adapt more easily to new situations, and can continue their lives even under difficult circumstances. An individual diagnosed with bipolar disorder who increases their psychological resilience will both prevent the triggering of attacks and gain skills to manage the symptoms of the illness. The program was designed focusing on areas emphasized in resilience theory, which can be developed and modified through education and life experience, and which also fall within the scope of cognitive behavioral therapy. These are internal locus of control, self-management, cognitive evaluation, social skills, social support, positive mood, stress management, and problem-solving skills. The intervention was each targeting specific therapeutic goals using relevant CBT techniques in 8weekly

    Behavioral: CBT-Based Psychological Resilience Enhancement Program for Individuals with BD

Interventions

  • BehavioralCBT-Based Psychological Resilience Enhancement Program for Individuals with BD

    Session 1 (Psychoeducation): Enhancing knowledge and insight regarding Bipolar Disorder via Socratic questioning and case formulation. Session 2 (Locus of Control): Shifting belief from external determinism to an internal locus of control using pie charts and didactic instruction. Session 3 (Self-Management): Acquiring skills to manage early warning signs and high-risk behaviors. Session 4 (Coping with Stress): Developing and implementing effective coping strategies. Session 5 (Problem-Solving): Utilizing a structured approach to resolve daily life problems. Session 6 (Thoughts and Emotions): Identifying emotional reactions to stimuli using the downward arrow technique, playing devil's advocate, and imagery. Session 7 (Realistic Thoughts): Fostering cognitive flexibility through examining evidence and evaluating thought functionality. Session 8 (Social Skills): Establishing external support systems to reinforce self-esteem and self-efficacy via role-playing.

    Also known as: Intervention group

06

What researchers measure

Primary outcomes

  1. Connor-Davidson Resilience Scale (CD-RISC)

    Connor-Davidson Resilience Scale (CD-RISC): Developed by Connor and Davidson in 2003 to measure individuals' psychological resilience, this scale primarily focuses on stress, coping, and adaptability. It is a 25-item, five-point Likert-type scale, with each item evaluated between 0 and 4, ranging from "not true at all" (0 points) to "true nearly all the time" (4 points). The maximum achievable score on the scale is 100. Higher scores denote greater psychological resilience, whereas lower scores indicate reduced resilience. During its development phase, the scale was administered to both normative and clinical populations. Data collected face-to-face via clinical interview

    Time frame: Baseline, 9 week and 21. week

  2. Brief Quality of Life in Bipolar Disorder Scale (Brief QoL.BD)

    Brief Quality of Life in Bipolar Disorder Scale (Brief QoL.BD): Developed by Michalak and Murray (2010) to evaluate the quality of life in patients with bipolar disorder. It is a 12-item quality of life scale specifically designed for bipolar disorder. It comprises one item for each of the following core domains: physical health, sleep, mood, cognition, leisure, social relationships, spirituality, finances, household, self-esteem, independence, and identity. The scale is rated on a five-point Likert scale ranging from 1 ("strongly disagree") to 5 ("strongly agree"), yielding a total score between 12 and 60. Higher scores indicate a better quality of life. Data collected face-to-face via clinical interview

    Time frame: Baseline, 9. week and 21. week

  3. Beck Depression Inventory (BDI)

    Beck Depression Inventory (BDI): This scale consists of 21 items designed to measure the affective, somatic, cognitive, and motivational symptoms of depression, with each item scored on a scale from 0 to 3. The total possible score ranges from 0 to 63. The assessment is based on the cumulative score obtained from all items, where higher scores indicate greater depression severity. In the present study, the BDI was utilized to verify the remission status required for the inclusion of patients diagnosed with bipolar disorder. Patients who scored 17 or lower on the inventory were included in the research. Data collected face-to-face via clinical interview

    Time frame: Baseline, 9. week and 21. week

  4. Young Mania Rating Scale (YMRS)

    Young Mania Rating Scale (YMRS): Developed by Young et al. in 1978, this scale is utilized to assess the severity of manic states. It comprises 11 Likert-type items, each assessing symptom severity across five levels. The total score ranges from 0 to 60, with higher scores denoting increased mania severity. In the current study, the YMRS was employed to confirm the remission status necessary for the inclusion of patients with bipolar disorder. Patients obtaining a score of 5 or lower on the scale were eligible for inclusion. Data collected face-to-face via clinical interview

    Time frame: Baseline, 9. week and 21. week

07

Study locations

1 site
  • Sivas Numune Hospital
    Sivas, Sivas 58000, Turkey (Türkiye)
08

References and documents

Publications

  • Bozikas VP, Parlapani E, Ntouros E, Bargiota SI, Floros G, Nazlidou EI, Garyfallos G. Resilience Predicts Social Functioning in Clinically Stable Patients With Bipolar Disorder. J Nerv Ment Dis. 2018 Jul;206(7):567-574. doi: 10.1097/NMD.0000000000000843. PubMed 29905660 ↗
  • Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, Gao K, Miskowiak KW, Grande I. Bipolar disorders. Nat Rev Dis Primers. 2018 Mar 8;4:18008. doi: 10.1038/nrdp.2018.8. PubMed 29516993 ↗
  • Tse S, Murray G, Chung KF, Davidson L, Ng KL, Yu CH. Exploring the recovery concept in bipolar disorder: a decision tree analysis of psychosocial correlates of recovery stages. Bipolar Disord. 2014 Jun;16(4):366-77. doi: 10.1111/bdi.12153. Epub 2013 Nov 22. PubMed 24261315 ↗
  • Sood A, Sharma V, Schroeder DR, Gorman B. Stress Management and Resiliency Training (SMART) program among Department of Radiology faculty: a pilot randomized clinical trial. Explore (NY). 2014 Nov-Dec;10(6):358-63. doi: 10.1016/j.explore.2014.08.002. Epub 2014 Aug 21. PubMed 25443423 ↗
  • Sood A, Prasad K, Schroeder D, Varkey P. Stress management and resilience training among Department of Medicine faculty: a pilot randomized clinical trial. J Gen Intern Med. 2011 Aug;26(8):858-61. doi: 10.1007/s11606-011-1640-x. Epub 2011 Jan 29. PubMed 21279454 ↗
  • Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006 Apr;188:313-20. doi: 10.1192/bjp.188.4.313. PubMed 16582056 ↗
  • Post RM, Leverich GS. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol. 2006 Fall;18(4):1181-211. doi: 10.1017/S0954579406060573. PubMed 17064434 ↗
  • Mizuno Y, Hofer A, Suzuki T, Frajo-Apor B, Wartelsteiner F, Kemmler G, Saruta J, Tsukinoki K, Mimura M, Fleischhacker WW, Uchida H. Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study. Schizophr Res. 2016 Aug;175(1-3):148-153. doi: 10.1016/j.schres.2016.04.047. Epub 2016 May 13. PubMed 27185483 ↗
  • Lee S, Lee J, Choi JY. The effect of a resilience improvement program for adolescents with complex congenital heart disease. Eur J Cardiovasc Nurs. 2017 Apr;16(4):290-298. doi: 10.1177/1474515116659836. Epub 2016 Jul 10. PubMed 27400701 ↗
  • Jones S, Mulligan LD, Higginson S, Dunn G, Morrison AP. The bipolar recovery questionnaire: psychometric properties of a quantitative measure of recovery experiences in bipolar disorder. J Affect Disord. 2013 May;147(1-3):34-43. doi: 10.1016/j.jad.2012.10.003. Epub 2012 Nov 22. PubMed 23182591 ↗
  • Hofer A, Mizuno Y, Wartelsteiner F, Wolfgang Fleischhacker W, Frajo-Apor B, Kemmler G, Mimura M, Pardeller S, Sondermann C, Suzuki T, Welte A, Uchida H. Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience. Eur Psychiatry. 2017 Oct;46:42-47. doi: 10.1016/j.eurpsy.2017.08.005. Epub 2017 Sep 1. PubMed 28992535 ↗
  • Echezarraga A, Las Hayas C, Gonzalez-Pinto AM, Jones S. The Resilience Questionnaire for Bipolar Disorder: Development and validation. Arch Psychiatr Nurs. 2017 Aug;31(4):376-385. doi: 10.1016/j.apnu.2017.04.010. Epub 2017 Apr 24. PubMed 28693874 ↗
  • Cohen AN, Hammen C, Henry RM, Daley SE. Effects of stress and social support on recurrence in bipolar disorder. J Affect Disord. 2004 Oct 1;82(1):143-7. doi: 10.1016/j.jad.2003.10.008. PubMed 15465589 ↗
  • Choi JW, Cha B, Jang J, Park CS, Kim BJ, Lee CS, Lee SJ. Resilience and impulsivity in euthymic patients with bipolar disorder. J Affect Disord. 2015 Jan 1;170:172-7. doi: 10.1016/j.jad.2014.08.056. Epub 2014 Sep 6. PubMed 25243746 ↗
  • Bowie CR, Best MW, Depp C, Mausbach BT, Patterson TL, Pulver AE, Harvey PD. Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis. Bipolar Disord. 2018 Nov;20(7):604-613. doi: 10.1111/bdi.12654. Epub 2018 May 18. PubMed 29777563 ↗
  • Angeler DG, Allen CR, Persson ML. Resilience concepts in psychiatry demonstrated with bipolar disorder. Int J Bipolar Disord. 2018 Feb 9;6(1):2. doi: 10.1186/s40345-017-0112-6. PubMed 29423550 ↗

Study documents

  • Protocol and statistical analysis plan · Aug 8, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Sap, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07748910
Lead sponsor
Cumhuriyet University
Responsible party
Ayse Aksoy, Dr (Doctor, (Phd. Psychiatric Nurse), Cumhuriyet University) — Principal investigator
First posted
Aug 6, 2026
Start date
May 14, 2021
Primary completion
Apr 2, 2023
Completion
Apr 3, 2023
Last update
Aug 6, 2026

Study contacts

AYŞE AKSOY, Dr.
principal investigator · Karaman Training and Research Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion